2024-09-18 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PODD
Insulet Corporation
|
Buy |
9.83% |
15.22% |
2024-08-29 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
8.73% |
-2.73% |
2024-09-02 |
NVCR
NovoCure Limited
|
Buy |
7.77% |
-0.17% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
7.82% |
6.04% |
2024-09-09 |
LMAT
LeMaitre Vascular, Inc.
|
Sell |
-3.72% |
0.25% |
2024-08-29 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-3.47% |
7.14% |
2024-08-29 |
CERS
Cerus Corporation
|
Sell |
-3.73% |
6.64% |
2024-09-05 |
The percentage of cash held in the portfolio is:
76.77%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
STAA |
Buy
All
|
0.59% |
Assets Rebalanced
None
2024-09-17 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PODD
Insulet Corporation
|
Buy |
9.82% |
14.42% |
2024-08-29 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
8.69% |
-3.83% |
2024-09-02 |
NVCR
NovoCure Limited
|
Buy |
7.79% |
-0.5% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
7.68% |
3.45% |
2024-09-09 |
STAA
STAAR Surgical Company
|
Sell |
-3.7% |
3.06% |
2024-08-28 |
LMAT
LeMaitre Vascular, Inc.
|
Sell |
-3.8% |
-1.08% |
2024-08-29 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-3.64% |
3.06% |
2024-08-29 |
CERS
Cerus Corporation
|
Sell |
-3.93% |
2.37% |
2024-09-05 |
The percentage of cash held in the portfolio is:
81.07%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
MGNX |
Sell
All
|
-2.28% |
AADI |
Sell
All
|
7.43% |
TVTX |
Sell
All
|
48.65% |
Assets Rebalanced
None
2024-09-13 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
AADI
Aadi Bioscience, Inc.
|
Buy |
6.31% |
1.14% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
9.82% |
12.73% |
2024-08-29 |
MGNX
MacroGenics, Inc.
|
Buy |
9.43% |
2.85% |
2024-09-02 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
8.77% |
-4.37% |
2024-09-02 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
9.26% |
31.25% |
2024-09-04 |
NVCR
NovoCure Limited
|
Buy |
7.63% |
-3.99% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
7.37% |
-2.15% |
2024-09-09 |
STAA
STAAR Surgical Company
|
Sell |
-3.58% |
7.41% |
2024-08-28 |
LMAT
LeMaitre Vascular, Inc.
|
Sell |
-3.77% |
0.97% |
2024-08-29 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-3.38% |
11.39% |
2024-08-29 |
CERS
Cerus Corporation
|
Sell |
-3.95% |
3.32% |
2024-09-05 |
The percentage of cash held in the portfolio is:
56.09%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
AGEN |
Sell
All
|
8.41% |
Assets Rebalanced
None
2024-09-12 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
AGEN
Agenus Inc.
|
Buy |
6.13% |
3.11% |
2024-08-23 |
AADI
Aadi Bioscience, Inc.
|
Buy |
6.59% |
5.14% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
9.75% |
11.4% |
2024-08-29 |
MGNX
MacroGenics, Inc.
|
Buy |
9.5% |
3.13% |
2024-09-02 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
8.76% |
-4.92% |
2024-09-02 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
9.04% |
27.5% |
2024-09-04 |
NVCR
NovoCure Limited
|
Buy |
7.62% |
-4.54% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
7.38% |
-2.56% |
2024-09-09 |
STAA
STAAR Surgical Company
|
Sell |
-3.64% |
6.36% |
2024-08-28 |
LMAT
LeMaitre Vascular, Inc.
|
Sell |
-3.73% |
2.57% |
2024-08-29 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-3.34% |
12.76% |
2024-08-29 |
CERS
Cerus Corporation
|
Sell |
-3.99% |
2.84% |
2024-09-05 |
The percentage of cash held in the portfolio is:
49.92%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
VREX |
Buy
All
|
2.22% |
APLS |
Sell
All
|
-3.75% |
Assets Rebalanced
None
2024-09-11 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
5.84% |
-1.69% |
2024-08-22 |
AGEN
Agenus Inc.
|
Buy |
5.93% |
-0.18% |
2024-08-23 |
AADI
Aadi Bioscience, Inc.
|
Buy |
6.37% |
1.71% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
9.69% |
10.8% |
2024-08-29 |
MGNX
MacroGenics, Inc.
|
Buy |
9.34% |
1.42% |
2024-09-02 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
8.7% |
-5.46% |
2024-09-02 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
9.47% |
33.75% |
2024-09-04 |
NVCR
NovoCure Limited
|
Buy |
7.47% |
-6.37% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
7.58% |
0.26% |
2024-09-09 |
STAA
STAAR Surgical Company
|
Sell |
-3.62% |
6.89% |
2024-08-28 |
LMAT
LeMaitre Vascular, Inc.
|
Sell |
-3.71% |
3.03% |
2024-08-29 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-3.26% |
14.88% |
2024-08-29 |
VREX
Varex Imaging Corporation
|
Sell |
-3.98% |
2.99% |
2024-09-05 |
CERS
Cerus Corporation
|
Sell |
-3.98% |
2.84% |
2024-09-05 |
The percentage of cash held in the portfolio is:
48.16%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
CDMO |
Buy
All
|
0.85% |
CARA |
Sell
All
|
-18.08% |
Assets Rebalanced
None
2024-09-10 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
5.93% |
0.21% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
5.35% |
-9.62% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
5.55% |
-6.22% |
2024-08-23 |
AADI
Aadi Bioscience, Inc.
|
Buy |
6.45% |
3.43% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
9.33% |
7.2% |
2024-08-29 |
MGNX
MacroGenics, Inc.
|
Buy |
9.01% |
-1.71% |
2024-09-02 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
8.51% |
-7.1% |
2024-09-02 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
9.45% |
33.96% |
2024-09-04 |
NVCR
NovoCure Limited
|
Buy |
7.3% |
-7.98% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
7.58% |
0.63% |
2024-09-09 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-3.28% |
15.41% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-3.59% |
7.17% |
2024-08-28 |
LMAT
LeMaitre Vascular, Inc.
|
Sell |
-3.7% |
2.83% |
2024-08-29 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-3.34% |
12.41% |
2024-08-29 |
VREX
Varex Imaging Corporation
|
Sell |
-3.57% |
12.56% |
2024-09-05 |
CERS
Cerus Corporation
|
Sell |
-3.91% |
4.27% |
2024-09-05 |
The percentage of cash held in the portfolio is:
46.93%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
BGNE |
Buy
All
|
-0.8% |
PACB |
Buy
All
|
-22.96% |
ALDX |
Sell
All
|
-6.49% |
Assets Rebalanced
None
2024-09-09 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
6.22% |
3% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
5.67% |
-6.12% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
5.47% |
-9.51% |
2024-08-23 |
AADI
Aadi Bioscience, Inc.
|
Buy |
6.66% |
4.57% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
9.34% |
5.05% |
2024-08-29 |
MGNX
MacroGenics, Inc.
|
Buy |
8.67% |
-7.41% |
2024-09-02 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
8.44% |
-9.84% |
2024-09-02 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
8.24% |
14.37% |
2024-09-04 |
ALDX
Aldeyra Therapeutics, Inc.
|
Buy |
7.89% |
-3.01% |
2024-09-05 |
NVCR
NovoCure Limited
|
Buy |
7.58% |
-6.48% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
7.69% |
0% |
2024-09-09 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-3.3% |
16.54% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-3.8% |
3.86% |
2024-08-28 |
LMAT
LeMaitre Vascular, Inc.
|
Sell |
-3.85% |
1.1% |
2024-08-29 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-3.41% |
12.41% |
2024-08-29 |
PACB
Pacific Biosciences of California, Inc.
|
Sell |
-4.55% |
-17.04% |
2024-08-29 |
BGNE
BeiGene, Ltd.
|
Sell |
-3.28% |
0.24% |
2024-09-02 |
VREX
Varex Imaging Corporation
|
Sell |
-4.11% |
1.28% |
2024-09-05 |
CERS
Cerus Corporation
|
Sell |
-3.99% |
4.27% |
2024-09-05 |
The percentage of cash held in the portfolio is:
48.43%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
ORGO |
Sell
All
|
-12.72% |
Assets Rebalanced
None
2024-09-06 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
5.91% |
-1.42% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
5.6% |
-6.71% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
5.62% |
-6.41% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
5.48% |
-8.59% |
2024-08-23 |
AADI
Aadi Bioscience, Inc.
|
Buy |
6.51% |
2.86% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
9.34% |
5.72% |
2024-08-29 |
MGNX
MacroGenics, Inc.
|
Buy |
8.95% |
-3.7% |
2024-09-02 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
8.74% |
-6.01% |
2024-09-02 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
7.4% |
3.44% |
2024-09-04 |
ALDX
Aldeyra Therapeutics, Inc.
|
Buy |
8.08% |
0% |
2024-09-05 |
NVCR
NovoCure Limited
|
Buy |
8.05% |
0% |
2024-09-06 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-3.34% |
14.93% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-3.78% |
3.61% |
2024-08-28 |
LMAT
LeMaitre Vascular, Inc.
|
Sell |
-3.82% |
1.07% |
2024-08-29 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-3.65% |
5.44% |
2024-08-29 |
PACB
Pacific Biosciences of California, Inc.
|
Sell |
-4.01% |
-3.7% |
2024-08-29 |
BGNE
BeiGene, Ltd.
|
Sell |
-3.26% |
0.1% |
2024-09-02 |
VREX
Varex Imaging Corporation
|
Sell |
-4.24% |
-2.31% |
2024-09-05 |
CERS
Cerus Corporation
|
Sell |
-4.08% |
1.42% |
2024-09-05 |
The percentage of cash held in the portfolio is:
50.51%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-09-05 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
5.68% |
-5.21% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
5.71% |
-4.59% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
5.62% |
-6.12% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
5.31% |
-11.33% |
2024-08-23 |
AADI
Aadi Bioscience, Inc.
|
Buy |
6.49% |
2.86% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
9.17% |
3.96% |
2024-08-29 |
MGNX
MacroGenics, Inc.
|
Buy |
8.78% |
-5.41% |
2024-09-02 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
9.23% |
-0.55% |
2024-09-02 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
7.48% |
4.69% |
2024-09-04 |
ALDX
Aldeyra Therapeutics, Inc.
|
Buy |
8.07% |
0% |
2024-09-05 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-3.42% |
12.67% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-3.81% |
2.72% |
2024-08-28 |
LMAT
LeMaitre Vascular, Inc.
|
Sell |
-3.83% |
0.61% |
2024-08-29 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-3.69% |
4.42% |
2024-08-29 |
PACB
Pacific Biosciences of California, Inc.
|
Sell |
-3.77% |
2.22% |
2024-08-29 |
BGNE
BeiGene, Ltd.
|
Sell |
-3.21% |
1.63% |
2024-09-02 |
VREX
Varex Imaging Corporation
|
Sell |
-4.13% |
0% |
2024-09-05 |
CERS
Cerus Corporation
|
Sell |
-4.13% |
0% |
2024-09-05 |
The percentage of cash held in the portfolio is:
58.46%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
CERS |
Sell
All
|
-11.34% |
EGRX |
Sell
All
|
-11.35% |
Assets Rebalanced
None
2024-09-04 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
5.85% |
-2.65% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
5.79% |
-3.53% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
5.8% |
-3.5% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
5.43% |
-9.51% |
2024-08-23 |
CERS
Cerus Corporation
|
Buy |
5.82% |
-7.98% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
6.29% |
-0.57% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
8.94% |
1.11% |
2024-08-29 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
7.92% |
-10.38% |
2024-08-29 |
MGNX
MacroGenics, Inc.
|
Buy |
8.7% |
-6.55% |
2024-09-02 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
9.31% |
0% |
2024-09-02 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
7.16% |
0% |
2024-09-04 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-3.62% |
8.03% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-3.92% |
0.15% |
2024-08-28 |
LMAT
LeMaitre Vascular, Inc.
|
Sell |
-3.8% |
1.75% |
2024-08-29 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-3.59% |
7.14% |
2024-08-29 |
PACB
Pacific Biosciences of California, Inc.
|
Sell |
-3.84% |
0.74% |
2024-08-29 |
BGNE
BeiGene, Ltd.
|
Sell |
-3.21% |
1.84% |
2024-09-02 |
The percentage of cash held in the portfolio is:
44.96%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
PINC |
Buy
All
|
-4.4% |
VERU |
Buy
All
|
-12.35% |
ARDX |
Sell
All
|
-11.62% |
NEOG |
Sell
All
|
-6.34% |
Assets Rebalanced
None
2024-09-02 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
5.64% |
-2.98% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
5.68% |
-2.4% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
5.92% |
1.77% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
6.11% |
4.96% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
5.48% |
-5.85% |
2024-08-23 |
CERS
Cerus Corporation
|
Buy |
5.82% |
-5.04% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
6.34% |
3.43% |
2024-08-27 |
NEOG
Neogen Corporation
|
Buy |
6.92% |
0.35% |
2024-08-28 |
PODD
Insulet Corporation
|
Buy |
8.5% |
-0.81% |
2024-08-29 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
8.47% |
-1.15% |
2024-08-29 |
MGNX
MacroGenics, Inc.
|
Buy |
9.02% |
0% |
2024-09-02 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
9.02% |
0% |
2024-09-02 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-3.8% |
0.38% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-3.89% |
-2.22% |
2024-08-28 |
PINC
Premier, Inc.
|
Sell |
-3.92% |
-2.93% |
2024-08-28 |
LMAT
LeMaitre Vascular, Inc.
|
Sell |
-3.8% |
-1.4% |
2024-08-29 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-3.84% |
-2.38% |
2024-08-29 |
VERU
Veru Inc.
|
Sell |
-3.79% |
-1.23% |
2024-08-29 |
PACB
Pacific Biosciences of California, Inc.
|
Sell |
-3.8% |
-1.48% |
2024-08-29 |
BGNE
BeiGene, Ltd.
|
Sell |
-3.17% |
0% |
2024-09-02 |
The percentage of cash held in the portfolio is:
47.08%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-29 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
5.62% |
-3.45% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
5.58% |
-4.2% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
6.03% |
3.53% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
6.04% |
3.79% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
5.44% |
-6.58% |
2024-08-23 |
CERS
Cerus Corporation
|
Buy |
5.78% |
-5.88% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
5.89% |
-4% |
2024-08-27 |
NEOG
Neogen Corporation
|
Buy |
6.75% |
-2.15% |
2024-08-28 |
PODD
Insulet Corporation
|
Buy |
8.57% |
0% |
2024-08-29 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
8.57% |
0% |
2024-08-29 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-3.68% |
3.4% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-3.75% |
1.42% |
2024-08-28 |
PINC
Premier, Inc.
|
Sell |
-3.82% |
-0.3% |
2024-08-28 |
LMAT
LeMaitre Vascular, Inc.
|
Sell |
-3.75% |
0% |
2024-08-29 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-3.75% |
0% |
2024-08-29 |
VERU
Veru Inc.
|
Sell |
-3.75% |
0% |
2024-08-29 |
PACB
Pacific Biosciences of California, Inc.
|
Sell |
-3.75% |
0% |
2024-08-29 |
The percentage of cash held in the portfolio is:
61.99%
New Assets Added
- LMAT
- AVXL
- VERU
- PACB
- PODD
- EGRX
Assets Removed
None
Assets Rebalanced
None
2024-08-28 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
5.62% |
-2.35% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
5.72% |
-0.64% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
5.98% |
3.89% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
6.02% |
4.66% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
5.92% |
2.93% |
2024-08-23 |
CERS
Cerus Corporation
|
Buy |
5.91% |
-2.52% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
5.82% |
-4% |
2024-08-27 |
NEOG
Neogen Corporation
|
Buy |
6.82% |
0% |
2024-08-28 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-3.66% |
2.74% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-3.76% |
0% |
2024-08-28 |
PINC
Premier, Inc.
|
Sell |
-3.76% |
0% |
2024-08-28 |
The percentage of cash held in the portfolio is:
63.38%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-27 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
5.64% |
-0.94% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
5.69% |
-0.05% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
6.09% |
7.07% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
6.14% |
7.87% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
6.11% |
7.31% |
2024-08-23 |
CERS
Cerus Corporation
|
Buy |
6% |
0% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
6% |
0% |
2024-08-27 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-3.65% |
2.08% |
2024-08-26 |
The percentage of cash held in the portfolio is:
61.99%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-26 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
5.71% |
-0.31% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
5.76% |
0.64% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
5.93% |
3.53% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
5.81% |
1.46% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
6.07% |
6.03% |
2024-08-23 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-3.75% |
0% |
2024-08-26 |
The percentage of cash held in the portfolio is:
74.46%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-23 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
5.51% |
-5.02% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
5.69% |
-1.79% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
5.63% |
-2.83% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
5.8% |
0% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
5.8% |
0% |
2024-08-23 |
The percentage of cash held in the portfolio is:
71.57%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-22 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
5.76% |
0% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
5.76% |
0% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
5.76% |
0% |
2024-08-22 |
The percentage of cash held in the portfolio is:
82.71%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-21 00:00:00
: Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is:
100%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
LXRX |
Buy
All
|
24.66% |
Assets Rebalanced
None
2024-08-19 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Sell |
-2.69% |
25.56% |
2024-07-31 |
The percentage of cash held in the portfolio is:
102.69%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
EGRX |
Buy
All
|
4.43% |
CYH |
Sell
All
|
-1.57% |
Assets Rebalanced
None
2024-08-09 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CYH
Community Health Systems, Inc.
|
Buy |
7% |
-2.95% |
2024-07-29 |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Sell |
-2.72% |
24.66% |
2024-07-31 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Sell |
-3.16% |
12.45% |
2024-07-31 |
The percentage of cash held in the portfolio is:
98.88%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
CPRX |
Buy
All
|
-6.15% |
PODD |
Buy
All
|
-2.48% |
NKTR |
Buy
All
|
10.37% |
Assets Rebalanced
None
2024-08-08 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CYH
Community Health Systems, Inc.
|
Buy |
6.63% |
-7.66% |
2024-07-29 |
PODD
Insulet Corporation
|
Sell |
-3.6% |
2.34% |
2024-07-19 |
NKTR
Nektar Therapeutics
|
Sell |
-3.22% |
12.59% |
2024-07-19 |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Sell |
-2.51% |
30.04% |
2024-07-31 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Sell |
-3.22% |
10.34% |
2024-07-31 |
CPRX
Catalyst Pharmaceuticals, Inc.
|
Sell |
-3.75% |
5.86% |
2024-08-01 |
The percentage of cash held in the portfolio is:
109.67%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
INGN |
Buy
All
|
-20.7% |
RMD |
Sell
All
|
1.39% |
RCM |
Sell
All
|
7.14% |
Assets Rebalanced
None
2024-08-06 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
RCM
R1 RCM Inc.
|
Buy |
6.08% |
7.06% |
2024-07-18 |
CYH
Community Health Systems, Inc.
|
Buy |
6.68% |
-5.3% |
2024-07-29 |
RMD
ResMed Inc.
|
Buy |
14.05% |
3.67% |
2024-07-31 |
PODD
Insulet Corporation
|
Sell |
-3.54% |
2.25% |
2024-07-19 |
NKTR
Nektar Therapeutics
|
Sell |
-3.13% |
13.33% |
2024-07-19 |
INGN
Inogen, Inc.
|
Sell |
-3.14% |
10.89% |
2024-07-31 |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Sell |
-2.41% |
31.84% |
2024-07-31 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Sell |
-3.25% |
8.02% |
2024-07-31 |
CPRX
Catalyst Pharmaceuticals, Inc.
|
Sell |
-3.52% |
10.15% |
2024-08-01 |
The percentage of cash held in the portfolio is:
92.18%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
BKD |
Sell
All
|
-5.42% |
FATE |
Sell
All
|
7.71% |
Assets Rebalanced
None
2024-08-05 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
BKD
Brookdale Senior Living Inc.
|
Buy |
4.03% |
-1.06% |
2024-07-16 |
FATE
Fate Therapeutics, Inc.
|
Buy |
4.85% |
19.02% |
2024-07-16 |
RCM
R1 RCM Inc.
|
Buy |
6.1% |
7.83% |
2024-07-18 |
CYH
Community Health Systems, Inc.
|
Buy |
6.88% |
-1.96% |
2024-07-29 |
RMD
ResMed Inc.
|
Buy |
14.5% |
7.5% |
2024-07-31 |
PODD
Insulet Corporation
|
Sell |
-3.63% |
-0.76% |
2024-07-19 |
NKTR
Nektar Therapeutics
|
Sell |
-3.2% |
11.11% |
2024-07-19 |
INGN
Inogen, Inc.
|
Sell |
-3.27% |
6.97% |
2024-07-31 |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Sell |
-2.68% |
23.77% |
2024-07-31 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Sell |
-3.41% |
2.95% |
2024-07-31 |
CPRX
Catalyst Pharmaceuticals, Inc.
|
Sell |
-3.73% |
4.47% |
2024-08-01 |
The percentage of cash held in the portfolio is:
83.55%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
RARE |
Buy
All
|
-17.98% |
HQY |
Sell
All
|
-11.82% |
SAVA |
Sell
All
|
95.11% |
SAGE |
Sell
All
|
-12.65% |
HCSG |
Sell
All
|
-6.49% |
Assets Rebalanced
None
2024-08-02 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
BKD
Brookdale Senior Living Inc.
|
Buy |
4.23% |
1.06% |
2024-07-16 |
FATE
Fate Therapeutics, Inc.
|
Buy |
5.25% |
25.45% |
2024-07-16 |
RCM
R1 RCM Inc.
|
Buy |
6.3% |
8.44% |
2024-07-18 |
CYH
Community Health Systems, Inc.
|
Buy |
7.1% |
-1.57% |
2024-07-29 |
HQY
HealthEquity, Inc.
|
Buy |
6.94% |
-3.84% |
2024-07-29 |
SAVA
Cassava Sciences, Inc.
|
Buy |
11.36% |
57.44% |
2024-07-29 |
SAGE
Sage Therapeutics, Inc.
|
Buy |
6.41% |
-11.19% |
2024-07-29 |
HCSG
Healthcare Services Group, Inc.
|
Buy |
2.94% |
-3.72% |
2024-07-30 |
RMD
ResMed Inc.
|
Buy |
14.3% |
3.13% |
2024-07-31 |
PODD
Insulet Corporation
|
Sell |
-3.74% |
-1.17% |
2024-07-19 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Sell |
-3.82% |
-3.2% |
2024-07-19 |
NKTR
Nektar Therapeutics
|
Sell |
-3.48% |
5.93% |
2024-07-19 |
INGN
Inogen, Inc.
|
Sell |
-3.58% |
0.87% |
2024-07-31 |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Sell |
-3.27% |
9.42% |
2024-07-31 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Sell |
-3.64% |
-0.84% |
2024-07-31 |
CPRX
Catalyst Pharmaceuticals, Inc.
|
Sell |
-3.94% |
1.8% |
2024-08-01 |
The percentage of cash held in the portfolio is:
60.63%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
SGRY |
Sell
All
|
18.28% |
RGNX |
Sell
All
|
4.72% |
AVNS |
Sell
All
|
12.13% |
CUTR |
Sell
All
|
-12.16% |
ANGO |
Sell
All
|
27.08% |
Assets Rebalanced
None
2024-08-01 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
SGRY
Surgery Partners, Inc.
|
Buy |
7.03% |
18.83% |
2024-07-12 |
RGNX
REGENXBIO Inc.
|
Buy |
6.63% |
12.12% |
2024-07-12 |
AVNS
Avanos Medical, Inc.
|
Buy |
6.68% |
12.94% |
2024-07-12 |
CUTR
Cutera, Inc.
|
Buy |
5.6% |
-5.41% |
2024-07-12 |
ANGO
AngioDynamics, Inc.
|
Buy |
8.5% |
27.9% |
2024-07-12 |
BKD
Brookdale Senior Living Inc.
|
Buy |
4.25% |
2.25% |
2024-07-16 |
FATE
Fate Therapeutics, Inc.
|
Buy |
5.69% |
37.02% |
2024-07-16 |
RCM
R1 RCM Inc.
|
Buy |
5.7% |
-1.15% |
2024-07-18 |
CYH
Community Health Systems, Inc.
|
Buy |
7.4% |
3.34% |
2024-07-29 |
HQY
HealthEquity, Inc.
|
Buy |
6.94% |
-3.09% |
2024-07-29 |
SAVA
Cassava Sciences, Inc.
|
Buy |
10.66% |
48.93% |
2024-07-29 |
SAGE
Sage Therapeutics, Inc.
|
Buy |
7.13% |
-0.36% |
2024-07-29 |
HCSG
Healthcare Services Group, Inc.
|
Buy |
3% |
-1.12% |
2024-07-30 |
RMD
ResMed Inc.
|
Buy |
14.1% |
2.5% |
2024-07-31 |
PODD
Insulet Corporation
|
Sell |
-3.66% |
0.31% |
2024-07-19 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Sell |
-3.87% |
-5.24% |
2024-07-19 |
NKTR
Nektar Therapeutics
|
Sell |
-3.65% |
0.74% |
2024-07-19 |
INGN
Inogen, Inc.
|
Sell |
-3.61% |
-0.76% |
2024-07-31 |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Sell |
-3.62% |
-0.9% |
2024-07-31 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Sell |
-3.64% |
-1.69% |
2024-07-31 |
CPRX
Catalyst Pharmaceuticals, Inc.
|
Sell |
-3.98% |
0% |
2024-08-01 |
The percentage of cash held in the portfolio is:
26.69%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
SMTI |
Buy
All
|
-6.87% |
OPK |
Sell
All
|
7.58% |
PDSB |
Sell
All
|
1.14% |
Assets Rebalanced
None
2024-07-31 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
OPK
OPKO Health, Inc.
|
Buy |
5.78% |
8.33% |
2024-07-11 |
PDSB
PDS Biotechnology Corporation
|
Buy |
5.24% |
-1.7% |
2024-07-11 |
SGRY
Surgery Partners, Inc.
|
Buy |
7.44% |
22.27% |
2024-07-12 |
RGNX
REGENXBIO Inc.
|
Buy |
6.84% |
12.43% |
2024-07-12 |
AVNS
Avanos Medical, Inc.
|
Buy |
6.59% |
8.4% |
2024-07-12 |
CUTR
Cutera, Inc.
|
Buy |
5.92% |
-2.7% |
2024-07-12 |
ANGO
AngioDynamics, Inc.
|
Buy |
8.72% |
27.73% |
2024-07-12 |
BKD
Brookdale Senior Living Inc.
|
Buy |
4.42% |
3.44% |
2024-07-16 |
FATE
Fate Therapeutics, Inc.
|
Buy |
5.63% |
31.88% |
2024-07-16 |
RCM
R1 RCM Inc.
|
Buy |
5.87% |
-1% |
2024-07-18 |
CYH
Community Health Systems, Inc.
|
Buy |
7.46% |
1.38% |
2024-07-29 |
HQY
HealthEquity, Inc.
|
Buy |
7.13% |
-3.16% |
2024-07-29 |
SAVA
Cassava Sciences, Inc.
|
Buy |
8.67% |
17.76% |
2024-07-29 |
SAGE
Sage Therapeutics, Inc.
|
Buy |
7.23% |
-1.73% |
2024-07-29 |
HCSG
Healthcare Services Group, Inc.
|
Buy |
3.11% |
-0.43% |
2024-07-30 |
RMD
ResMed Inc.
|
Buy |
14.14% |
0% |
2024-07-31 |
PODD
Insulet Corporation
|
Sell |
-3.75% |
0.6% |
2024-07-19 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Sell |
-3.94% |
-4.51% |
2024-07-19 |
NKTR
Nektar Therapeutics
|
Sell |
-3.89% |
-2.96% |
2024-07-19 |
SMTI
Sanara MedTech Inc.
|
Sell |
-3.68% |
0% |
2024-07-31 |
INGN
Inogen, Inc.
|
Sell |
-3.68% |
0% |
2024-07-31 |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Sell |
-3.68% |
0% |
2024-07-31 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Sell |
-3.68% |
0% |
2024-07-31 |
The percentage of cash held in the portfolio is:
16.14%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
SMTI |
Sell
All
|
-8.69% |
CLDX |
Sell
All
|
-12.36% |
Assets Rebalanced
None
2024-07-30 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
OPK
OPKO Health, Inc.
|
Buy |
5.68% |
8.33% |
2024-07-11 |
PDSB
PDS Biotechnology Corporation
|
Buy |
5.69% |
8.52% |
2024-07-11 |
SGRY
Surgery Partners, Inc.
|
Buy |
7.28% |
21.76% |
2024-07-12 |
RGNX
REGENXBIO Inc.
|
Buy |
6.75% |
12.9% |
2024-07-12 |
AVNS
Avanos Medical, Inc.
|
Buy |
6.46% |
8.03% |
2024-07-12 |
CUTR
Cutera, Inc.
|
Buy |
5.65% |
-5.41% |
2024-07-12 |
ANGO
AngioDynamics, Inc.
|
Buy |
8.39% |
24.96% |
2024-07-12 |
BKD
Brookdale Senior Living Inc.
|
Buy |
4.38% |
4.37% |
2024-07-16 |
FATE
Fate Therapeutics, Inc.
|
Buy |
5.84% |
39.07% |
2024-07-16 |
RCM
R1 RCM Inc.
|
Buy |
5.67% |
-2.61% |
2024-07-18 |
CLDX
Celldex Therapeutics, Inc.
|
Buy |
7.29% |
-4.26% |
2024-07-26 |
SMTI
Sanara MedTech Inc.
|
Buy |
6.84% |
-5.45% |
2024-07-29 |
CYH
Community Health Systems, Inc.
|
Buy |
7.36% |
1.77% |
2024-07-29 |
HQY
HealthEquity, Inc.
|
Buy |
7.11% |
-1.69% |
2024-07-29 |
SAVA
Cassava Sciences, Inc.
|
Buy |
8.74% |
20.78% |
2024-07-29 |
SAGE
Sage Therapeutics, Inc.
|
Buy |
7.11% |
-1.64% |
2024-07-29 |
HCSG
Healthcare Services Group, Inc.
|
Buy |
3.07% |
0% |
2024-07-30 |
PODD
Insulet Corporation
|
Sell |
-3.65% |
1.61% |
2024-07-19 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Sell |
-3.92% |
-5.75% |
2024-07-19 |
NKTR
Nektar Therapeutics
|
Sell |
-3.74% |
-0.74% |
2024-07-19 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
RMD |
Buy
All
|
-5.84% |
PTGX |
Sell
All
|
-7.35% |
Assets Rebalanced
None
2024-07-29 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
OPK
OPKO Health, Inc.
|
Buy |
5.82% |
12.12% |
2024-07-11 |
PDSB
PDS Biotechnology Corporation
|
Buy |
5.71% |
10.23% |
2024-07-11 |
SGRY
Surgery Partners, Inc.
|
Buy |
7.4% |
25.32% |
2024-07-12 |
RGNX
REGENXBIO Inc.
|
Buy |
6.66% |
12.75% |
2024-07-12 |
AVNS
Avanos Medical, Inc.
|
Buy |
6.46% |
9.25% |
2024-07-12 |
CUTR
Cutera, Inc.
|
Buy |
6.07% |
2.7% |
2024-07-12 |
ANGO
AngioDynamics, Inc.
|
Buy |
8.28% |
24.8% |
2024-07-12 |
BKD
Brookdale Senior Living Inc.
|
Buy |
4.39% |
5.69% |
2024-07-16 |
FATE
Fate Therapeutics, Inc.
|
Buy |
5.8% |
39.85% |
2024-07-16 |
RCM
R1 RCM Inc.
|
Buy |
5.75% |
-0.19% |
2024-07-18 |
PTGX
Protagonist Therapeutics, Inc.
|
Buy |
7.24% |
-3.84% |
2024-07-25 |
CLDX
Celldex Therapeutics, Inc.
|
Buy |
7.65% |
1.6% |
2024-07-26 |
SMTI
Sanara MedTech Inc.
|
Buy |
7.15% |
0% |
2024-07-29 |
CYH
Community Health Systems, Inc.
|
Buy |
7.15% |
0% |
2024-07-29 |
HQY
HealthEquity, Inc.
|
Buy |
7.15% |
0% |
2024-07-29 |
SAVA
Cassava Sciences, Inc.
|
Buy |
7.15% |
0% |
2024-07-29 |
SAGE
Sage Therapeutics, Inc.
|
Buy |
7.15% |
0% |
2024-07-29 |
PODD
Insulet Corporation
|
Sell |
-3.64% |
0.85% |
2024-07-19 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Sell |
-3.85% |
-4.86% |
2024-07-19 |
NKTR
Nektar Therapeutics
|
Sell |
-3.75% |
-2.22% |
2024-07-19 |
RMD
ResMed Inc.
|
Sell |
-3.75% |
0% |
2024-07-29 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
- RMD
- SMTI
- CYH
- HQY
- SAVA
- SAGE
Assets Removed
Asset |
Action |
Perf % |
WAT |
Buy
All
|
-5.03% |
ATRC |
Sell
All
|
-12.65% |
Assets Rebalanced
None
2024-07-26 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
OPK
OPKO Health, Inc.
|
Buy |
5.62% |
7.58% |
2024-07-11 |
PDSB
PDS Biotechnology Corporation
|
Buy |
5.84% |
11.93% |
2024-07-11 |
SGRY
Surgery Partners, Inc.
|
Buy |
7.16% |
20.35% |
2024-07-12 |
RGNX
REGENXBIO Inc.
|
Buy |
6.73% |
13.22% |
2024-07-12 |
AVNS
Avanos Medical, Inc.
|
Buy |
6.44% |
8.22% |
2024-07-12 |
CUTR
Cutera, Inc.
|
Buy |
5.63% |
-5.41% |
2024-07-12 |
ANGO
AngioDynamics, Inc.
|
Buy |
8.18% |
22.51% |
2024-07-12 |
BKD
Brookdale Senior Living Inc.
|
Buy |
4.32% |
3.44% |
2024-07-16 |
FATE
Fate Therapeutics, Inc.
|
Buy |
5.8% |
38.82% |
2024-07-16 |
ATRC
AtriCure, Inc.
|
Buy |
6.11% |
-7% |
2024-07-17 |
RCM
R1 RCM Inc.
|
Buy |
5.75% |
-0.84% |
2024-07-18 |
PTGX
Protagonist Therapeutics, Inc.
|
Buy |
7.53% |
-0.76% |
2024-07-25 |
CLDX
Celldex Therapeutics, Inc.
|
Buy |
7.58% |
0% |
2024-07-26 |
PODD
Insulet Corporation
|
Sell |
-3.61% |
2.09% |
2024-07-19 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Sell |
-3.89% |
-5.33% |
2024-07-19 |
NKTR
Nektar Therapeutics
|
Sell |
-3.75% |
-1.48% |
2024-07-19 |
WAT
Waters Corporation
|
Sell |
-3.74% |
-2.5% |
2024-07-22 |
The percentage of cash held in the portfolio is:
32.32%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-07-25 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
OPK
OPKO Health, Inc.
|
Buy |
5.68% |
7.58% |
2024-07-11 |
PDSB
PDS Biotechnology Corporation
|
Buy |
5.64% |
6.96% |
2024-07-11 |
SGRY
Surgery Partners, Inc.
|
Buy |
6.98% |
16.16% |
2024-07-12 |
RGNX
REGENXBIO Inc.
|
Buy |
6.45% |
7.32% |
2024-07-12 |
AVNS
Avanos Medical, Inc.
|
Buy |
6.41% |
6.7% |
2024-07-12 |
CUTR
Cutera, Inc.
|
Buy |
5.85% |
-2.7% |
2024-07-12 |
ANGO
AngioDynamics, Inc.
|
Buy |
8.07% |
19.58% |
2024-07-12 |
BKD
Brookdale Senior Living Inc.
|
Buy |
4.38% |
3.7% |
2024-07-16 |
FATE
Fate Therapeutics, Inc.
|
Buy |
5.62% |
33.16% |
2024-07-16 |
ATRC
AtriCure, Inc.
|
Buy |
6.3% |
-5.18% |
2024-07-17 |
RCM
R1 RCM Inc.
|
Buy |
5.91% |
0.92% |
2024-07-18 |
PTGX
Protagonist Therapeutics, Inc.
|
Buy |
7.66% |
0% |
2024-07-25 |
PODD
Insulet Corporation
|
Sell |
-3.72% |
0.3% |
2024-07-19 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Sell |
-3.93% |
-5.45% |
2024-07-19 |
NKTR
Nektar Therapeutics
|
Sell |
-3.9% |
-4.44% |
2024-07-19 |
WAT
Waters Corporation
|
Sell |
-3.72% |
-0.86% |
2024-07-22 |
The percentage of cash held in the portfolio is:
40.32%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-07-23 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
OPK
OPKO Health, Inc.
|
Buy |
5.87% |
10.61% |
2024-07-11 |
PDSB
PDS Biotechnology Corporation
|
Buy |
5.88% |
10.8% |
2024-07-11 |
SGRY
Surgery Partners, Inc.
|
Buy |
6.67% |
10.29% |
2024-07-12 |
RGNX
REGENXBIO Inc.
|
Buy |
6.08% |
0.47% |
2024-07-12 |
AVNS
Avanos Medical, Inc.
|
Buy |
6.43% |
6.28% |
2024-07-12 |
CUTR
Cutera, Inc.
|
Buy |
6.66% |
10.14% |
2024-07-12 |
ANGO
AngioDynamics, Inc.
|
Buy |
7.9% |
16.31% |
2024-07-12 |
BKD
Brookdale Senior Living Inc.
|
Buy |
4.37% |
2.78% |
2024-07-16 |
FATE
Fate Therapeutics, Inc.
|
Buy |
4.98% |
17.22% |
2024-07-16 |
ATRC
AtriCure, Inc.
|
Buy |
6.29% |
-5.85% |
2024-07-17 |
RCM
R1 RCM Inc.
|
Buy |
6.02% |
2.15% |
2024-07-18 |
PODD
Insulet Corporation
|
Sell |
-3.74% |
0.37% |
2024-07-19 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Sell |
-3.9% |
-3.93% |
2024-07-19 |
NKTR
Nektar Therapeutics
|
Sell |
-4.06% |
-8.15% |
2024-07-19 |
WAT
Waters Corporation
|
Sell |
-3.77% |
-1.49% |
2024-07-22 |
The percentage of cash held in the portfolio is:
48.31%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
VRDN |
Sell
All
|
13.4% |
RYTM |
Sell
All
|
16.66% |
Assets Rebalanced
None